CONNECT WITH US
HealthTech

HealthTech

Psilocybin may improve a difficult-to-treat symptom of depression, study finds

Medical Xpress logo

Published on

Add as a preferred source on Google
Psilocybin may improve a difficult-to-treat symptom of depression, study finds

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

New research from the University of Colorado Anschutz suggests that psilocybin may help improve anhedonia, the loss of interest or ability to experience pleasure, in people with treatment-resistant depression. In a clinical trial, researchers found significant improvement in this difficult-to-treat symptom eight weeks after treatment, offering new insight into psilocybin's potential role in depression care.

Anhedonia is one of the most difficult symptoms of depression to treat. It can affect a person's ability to enjoy everyday activities, connect with others and experience a sense of meaning, even when other symptoms of depression improve.

The study, published in the Journal of Affective Disorders, is the first randomized, placebo-controlled clinical trial to specifically investigate psilocybin's effects on anhedonia in people with treatment-resistant major depressive disorder, a form of depression that has not responded adequately to previous treatments.

Researchers found that participants who received 25 milligrams of psilocybin experienced significantly greater improvement in anhedonia eight weeks after treatment compared with participants who received a 1-milligram dose.

However, the study did not find a statistically significant difference between the groups on its primary measure of anhedonia at one week. The difference observed at eight weeks was a secondary finding, suggesting that psilocybin's potential effects on this symptom warrant further investigation.

, associate professor of psychiatry at the University of Colorado Anschutz.



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.